Rutul R. Shah
Chief Operating OfficerMr. Rutul R. Shah serves as Chief Operating Officer at Precigen, Inc. since October 01, 2022, where he is responsible for strategic management of the Company's portfolio and ensure agility and operational efficiency in executing Company priorities while collaborating closely with Finance, Business Development and R&D. From February 16, 2020 to October 1, 2022 Mr. Shah served as our Vice President & Head of Operations. He joined Precigen, Inc. in 2014. Mr. Shah has broad experience in alliance management, portfolio management, program and project management and operations. Prior to joining Precigen, Mr. Shah spent more than a decade in scientific positions focused on the development of protein, antibody, gene and cell therapy drugs at Zyngenia, Teva Biopharmaceuticals USA, CoGenesys and Human Genome Sciences. Mr. Shah graduated with a BE degree in Chemical Engineering from Gujarat University in India and MS degree in Bioengineering from the University of Illinois, Chicago.
Positions
- Company NamePrecigen, Inc.Stock CodePGENPositionChief Operating OfficerColleagues
